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Background: Stroke is one of the leading causes of death and disability in China. Current treatments for stroke are
limited and achieve no optimal effect. Acupuncture is widely used in the treatment of stroke and in improving the
quality of life for patients in China. In most previous clinical studies, the effects of acupuncture have been diverse,
and few well-designed randomized controlled trials have been conducted to investigate the long-term effect of
acupuncture on acute stroke recovery.
Method: Three hundred and twenty eight subjects with acute cerebral apoplexy will be recruited. The patients will
be randomized into two different groups: the intervention group will receive acupuncture treatment together with
Western standard treatment for 2 weeks plus the secondary prevention treatment for 22 weeks; the control group
will receive only the Western standard treatment for 2 weeks and the secondary prevention treatment for 22 weeks.
The primary outcome measures are Barthel Index and the Stroke-Specific Quality Of Life. The secondary outcome
measures are the National Institutes of Health Stroke Scale and Modified Rankin Scale. All assessments will be
conducted at the baseline and at weeks 4, 12 and 24 of follow-up.
Discussion: This study will evaluate the effects of acupuncture on the long-term recovery of acute stroke and on
improving the quality of life of the patients. The results of this study will help establish optimal integrated
therapeutic strategies for patients with stroke.
Trial registration: Current Controlled Trials ISRCTN29932220Background
With the rapid economic development in China, the
Chinese healthcare system has seen significant improve-
ments. However, tough challenges remain in the treat-
ment of stroke, the leading cause of death and disability
in China [1]. Although stroke is a global epidemic, about
85% of all stroke deaths are registered in low- and
middle-income countries, and patients in these countries
also account for 87% of total stroke-related losses in
terms of disability-adjusted life years [2]. For example, in
China, stroke morbidity is 89.6–314 out of every 100,000
males and 76.7–212.2 out of every 100,000 females. The
mortality from stroke in urban areas is 127.96 out of* Correspondence: wlp5558@sina.com
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reproduction in any medium, provided the orevery 100,000 people, and in rural areas 115.2 out of
every 100,000 people [3].
Poor control of vascular risk factors and limited access
to acute and primary care are the most common reasons
for the high mortality and rate of disability after stroke.
In addition, secondary prevention-an important possible
approach in the treatment of stroke-is also largely lack-
ing in low- and middle-income countries [4].
Despite the availability of effective therapies, optimal
management of stroke remains problematic. Current
therapeutic strategies focus on restoring blood flow
in ischemic strokes, and on controlling bleeding in
hemorrhagic strokes. These approaches are not effective
for long-term stroke recovery or for enhancing the qual-
ity of life of patients. For example, thrombolytic therapy
carries the risk of hemorrhage and is limited to the first
three hours after the stroke [5-7].
Acupuncture has been practiced in China for more
than 3,000 years [8], and is traditionally considered as aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Recently, there have been many reports of its benefits in
the treatment of stroke [9-11]. However, the effect size
of these clinical studies was underestimated because of
methodological flaws, including inadequate statistical ana-
lysis, a failure to describe differences in baseline stroke se-
verity, and an inadequate assessment period [11,12].
Thus, acupuncture may be more effective in assisting
stroke recovery than has generally been reported, espe-
cially when the stroke is moderately severe.
In this study protocol, we describe the design of a par-
allel multi-center randomized controlled trial. The aims
of the study are to provide an alternative strategy for
stroke treatment and thereby improve stroke care, to il-
lustrate the potential benefits of acupuncture in stroke




The study is a parallel multi-center randomized controlled
trial. It will compare the combination of acupuncture
and Western medicine treatments with standard Western
stroke treatment given alone during the acute phase
(24 weeks) after stroke. The Barthel Index (BI) and
Stroke-Specific Quality Of Life (SS-QOL) will be assessed
as primary outcome measures, and the secondary out-
come measures are the National Institutes of Health
Stroke Scale (NIHSS) and modified Rankin Scale (mRS).
All assessments will be conducted at baseline and at weeks
4, 12 and 24 of follow-up. The study design is detailed in
Figure 1.
Ethics
The study is being conducted in accordance with the
Medical Research Council Ethics Guidelines. Ethical ap-
proval and scientific review of this study were obtained
from the Research Ethical Committee of the Beijing
Hospital of Traditional Chinese Medicine on 22 January
2010 (Ref: 201002–1).
Informed consent
Prior to the study, participating patients will receive
written and oral information about the study process
and the required time commitment.
Patients
All patients admitted to the Neurology Department of Bei-
jing Shunyi District Hospital and Beijing Pinggu District
Hospital with acute ischemic stroke will be considered for
recruitment. Patients of any age with a recent (within 14
days), clinically and computer tomography/magnetic res-
onance imaging-confirmed ischemic stroke who are able
to give informed consent will be eligible for inclusion.Inclusion criteria
The inclusion criteria are: (1) stroke diagnosed according
to the criteria of cerebral arterial thrombosis in Western
medicine and apoplexy in Chinese medicine; (2) acute
cerebral arterial thrombosis that occurred in the past
14 days; (3) male or female aged 40–75 years; (4) NIHSS
grade from 4 to 21; (5) Glasgow Coma Score ≥ 7;
(6) patients with their first attack or with a history of
cerebral stroke but with no serious deformity and mRS
grade ≤ 1; and (7) voluntary participation in the trial and
provision of informed consent.
Exclusion criteria
The exclusion criteria are: (1) ongoing thrombolytic
treatment; (2) participation in other clinical trials,
currently or in the last 3 months; (3) severe primary
diseases of the cardiovascular system, liver, kidney,
or hematopoietic system; (4) psychological disorders;
(5) pregnancy or breast-feeding; and (6) inborn handicaps.
Randomization
The computer-generated randomization is conducted
by the Epidemiological Research Center of the Third
Affiliated Hospital of Beijing University. Sequential, sealed,
opaque envelopes are used for allocation, which occurs
after the acupuncturist’s evaluation (concealed allocation).
Interventions
A total of 328 patients in the acute stage of cerebral
apoplexy will be recruited. The patients are randomly
divided into two different groups: 1) the intervention
group and 2) the control group. The intervention group
will receive acupuncture treatment in addition to the
Western medicine standard treatment for 2 weeks and the
secondary prevention treatment for 22 weeks, and the
control group will receive standard Western-medicine
therapy for 2 weeks and the secondary prevention treat-
ment for 22 weeks. Both groups will be evaluated at base-
line and at 4, 12 and 24 weeks of treatment.
Intervention group
Seven main acupoints will be stimulated: Baihui (Du-20),
Quchi (LI-11), Shousanli (LI-10), Hegu (LI-4), Zusanli (ST-
36), Yanglingquan (GB-34), and Sanyinjiao (SP-6). Acu-
points association will be used according to the theory of
Chinese medicine and the unique symptoms of the
patients. The following additional acupoints are commonly
used: Jianyu (LI-15), Huantiao (GB-10), Qiuxu (GB40),
twelve well-jing points, Jinjin (EX-HN 12), Yuye (EX-HN
13), Yamen (DU-15), Lianquan (RN 23), Tianshu (ST-25),
Fenglong (ST-40), and limb spasm assists with fire needles.
The acupoints will be stimulated by filiform stainless-
steel needles (0.30 mm diameter, 40 mm length). Patients
in the acute stroke stage will be manually stimulated to
Acupuncture(5 times weekly till 12th
week ) +  
secondary prevention treatment 
Standard therapy 
Met inclusion criteria; Informed consents 
Patients with Acute ischemic stroke  
Intervention group (n=164) 
Randomization (n=328) 
Control group (n=164) 
Assessed at 4th, 12th,24th week :  
Barthel Index (BI) ;  
Stroke-Specific Quality Of Life (SS-QOL) ;  
The National Institutes of Health Stroke Scale (NIHSS) ; 
Modified Rankin Scale (mRS) 





Figure 1 Flowchart of the study design.
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above, with a needling depth of 30 mm. The needles will re-
main for 30 minutes per treatment, and the treatments are
given five times per week. At the same time, Jinjin (EX-HN
12), Yuye (EX-HN 13), Sishencong (EX-HN 1) and the
twelve jing well points will be stimulated by quick insertion
of the tri-ensiform needles to induce bleeding. The stim-
ulation will last for two weeks. Stimulation of Jianyu
(LI-15), Huantiao (GB-10), Qiuxu (GB40), Yamen (DU-
15), Lianquan (RN 23), Tianshu (ST-25) and Fenglong
(ST-40) will be performed according to the specific syn-
drome of each patient. For instance, Jianyu (LI-15) and
Huantiao (GB-10) will be selected for hemiplegic paralysis;
Yamen (DU-15) and Lianquan (RN 23) for aphasia; and
Tianshu (ST-25) and Fenglong (ST-40) for constipation.
Western medicine standard therapy, such as inhibi-
tion of platelet aggregation, control of blood pressure,routine physiotherapy, occupational therapy, glucose con-
trol, dyslipidemia control, and dehydration treatment
if necessary, will be given for 2 weeks. The secondary
prevention treatments, such as blood pressure control,
inhibition of platelet aggregation, glucose control, and
dyslipidemia control, will be given for 22 weeks.
Control group
The patients will receive the standard therapy for 2 weeks
and the secondary prevention treatment for 22 weeks as
mentioned above.
Outcome measures
Participant demographics and general status
Demographic information such as sex, age, marital status,
educational background, indicators of social economic
status (e.g. household income) and time from attack will
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(respiration rate, pulse, blood pressure and temperature)
will be measured by nurses.
Primary
The BI The BI is a scale that measures ten basic aspects
of activity related to self-care and mobility [13]. For the
Chinese version, the BI is translated into Chinese, and
the ten items are: feeding, bathing, grooming, dressing,
continence of bowels and bladder, transferring to and
from a toilet, moving from wheelchair to bed and return,
walking on level surface for 45 meters, and going up and
down stairs. The sum of the scores for the individual
items forms the total score. The normal score is 100,
and lower scores indicate greater dependency. If a per-
son manages about 50% of the items independently,
their score would fall in middle.
The BI will be assessed by the investigators at baseline
and at 4, 12 and 24 weeks after the stroke. The total BI
scores will be recorded and classified into three groups:
independent (BI score ≥ 60), with help (BI score 40–60),
and dependent (≤ 40).
The SS-QOL The SS-QOL is a patient-reported out-
come measure intended to provide an assessment of
health-related quality of life, specific to patients with
stroke [14]. The SS-QOL questionnaire consists of 49
items in the 12 domains of energy, family roles, lan-
guage, mobility, mood, personality, self-care, social roles,
thinking, upper extremity function, vision, and work/
productivity. Scoring of the SS-QOL is rated on a 5-
point Likert scale. Response options are scored as 5 (“no
help needed/no trouble at all/strongly disagree”), 4 (“a
little help/a little trouble/moderately disagree”), 3 (“some
help/some trouble/neither agree nor disagree”), 2 (“a lot
of help/a lot of trouble/moderately agree”), and 1 (“total
help/could not do it at all/strongly agree”). The domains
are scored separately, and a total score is also calculated,
with higher scores indicating better function.
An SS-QOL version translated to Chinese will be pro-
vided to the patients at baseline and at 4, 12 and 24 weeks.
The test-retest reliability, internal consistency, construct,
and convergent validity of the SS-QOL in patients with
stroke will be ascertained by the investigators.
Secondary
The NIHSS The NIHSS is a standardized stroke severity
scale used to describe neurological deficits in stroke
patients. The NIHSS comprises tests of 11 items, includ-
ing the level of consciousness, selected cranial nerves,
motor function, sensory function, cerebellar function,
language, and inattention (neglect) et al. Total scores
range from 0 to 42, with scores above 25 indicating very
severe neurological impairment, scores of 5–24 suggesting moderately severe to severe impairment,
and scores below 5 indicating mild impairment [15].
Each patient will be scored by a trained, certified
investigator at the time of initial stroke evaluation (base-
line) and at 4, 12 and 24 weeks after treatment.
The mRS The mRS is another commonly used scale
that measures disability or dependence in activities of
daily living in stroke victims [16]. Consenting patients
with stroke in this trial will have the mRS performed by
the investigators at baseline and at 4, 12 and 24 weeks.
Follow-up
Assessments will be conducted at baseline and at weeks
4, 12 and 24 of follow-up. The follow-up assessment
is designed to evaluate the long-term effect of acupunc-
ture treatment.
Quality control
The staff will be specially trained to treat stroke patients;
they will take part in special education programs to im-
prove their knowledge of stroke. They will be trained
to know the inclusion and exclusion criteria, and all the
occupational therapists will master the acupuncture
methods used in this trial.
Patients will be allocated to different groups using a
random number table to avoid selection bias. Blinding
will be used both for the evaluators and the patients
to avoid measurement bias and the influence of psycho-
logical factors on the therapy effect. All statistical anal-
ysis will be conducted by the statistician, who will be
blinded to the grouping and analysis procedure.
Statistical analysis
The statistical analysis will be performed by the Epi-
demiological Research Center of the Third Affiliated
Hospital of Beijing University.
The quantitative data are presented as mean ± stand-
ard deviation and will be analyzed using analysis of vari-
ance when normally distributed. Non-parametric data
will be analyzed using the Wilcoxon test with repeated
measures. Enumeration data are presented as frequen-
cies or ratios. If the outcome variables are two-way 2×2
contingency tables, chi-square tests or Fisher exact prob-
ability tests will be performed. If they are one-way 2×4
ordered data, Ridit analyses will be performed.
Statistical analyses will be conducted using SPSS ver-
sion 13.0 (SPSS, Chicago, IL, USA). The P-value cut-off
for statistical significance is defined as P < 0.05, and all
statistical tests are two-tailed.
Discussion
Acupuncture is widely used to enhance stroke recovery
in Eastern countries. However, a recent randomized
controlled trial demonstrated that acupuncture has no
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analysis of sham-controlled randomized clinical trials
concluded that there is insufficient evidence to support
the use of acupuncture for functional recovery after
stroke [18]. These data have led to ongoing controversy
regarding the use of acupuncture therapy after stroke,
despite the thousands years of evidence from traditional
Chinese medicine practice.
The occupational therapists’ technique in the manipu-
lation and selection of acupoints is the most important
factor that determines the efficacy of acupuncture ther-
apy [19]. In the present study, all occupational therapists
are experts with more than ten years of acupuncture
practice and plenty of experience with stroke treatments.
The acupoints selected in this trial correspond to a com-
plex prescription for stroke therapy originating in over
60 years of clinical application. Moreover, all the occupa-
tional therapists will receive special training to achieve a
sound understanding of the acupoint selection and to
normalize the practices across different therapists. The
trial complies with the STRICTA (STandards for Report-
ing Interventions in Controlled Trials of Acupuncture).
The efficacy of acupuncture is different at different levels
of stroke severity. It may have limit efficacy in very severe
strokes, particularly in cases of extensive brain damage
[20,21]. However, for mild or moderately severe strokes,
acupuncture might be a superior treatment. In this trial,
we will recruit patients with moderately severe acute
strokes without severe deformity, and with NIHSS grades
from 4 to 21, Glasgow Coma Scores of greater than or
equal to 7, and mRS grades of less than or equal to 1.
Recovery of function after stroke is a long steady
process that continues for several weeks or even months
before reaching a stable phase. The effects of acupunc-
ture occur within the same time frame. Several previous
studies did not show any beneficial effect of acupunc-
ture, and this may in part be explained by an assess-
ment of efficacy too soon after acupuncture treatment
(in most cases 2–3 weeks after stroke) [22,23]. An
assessment or reassessment at a minimum of 4 weeks,
and ideally at least 3 to 6 months after the completion
of treatment is essential. We followed the time course
of the normal process of stroke recovery in design-
ing our study protocol. Thus, we will assess efficacy
at baseline and at 4, 12 and 24 weeks after acupunc-
ture intervention.
The primary endpoint for this study is the change in
the quality of life in the intervention and control groups,
from baseline to 4, 12 and 24 weeks post-therapy.
Neurological deficits, disability, and dependence in activ-
ities of daily living will be evaluated by NIHSS and mRS
as the secondary endpoints.
Many acupuncturists consider the main effect of
acupuncture on the human body after stroke to be therehabilitation of motor function, whereas few have consid-
ered the patients’ life quality, which includes factors such
as dependence in activities of daily living, feeding, dres-
sing, and continence of bowels and bladder. To address
this, we will use the BI and SS-QOL questionnaires to
measure the quality of life as the primary outcomes.
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